Clinical Trial Update: Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of a bismuth quadruple therapy containing cefuroxime and tetracycline as first-line treatment for Heli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth quadruple therapy containing cefuroxime and tetracycline

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN